|
業務類別
|
Biotechnology |
|
業務概覽
|
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. |
| 公司地址
| 1150 Veterans Boulevard, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 905 407-1049 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.nkartatx.com |
| 員工數量
| 157 |
| Dr. Shawn Rose, M.D.,PhD |
Chief Medical Officer and Head, Research and Development |
-- |
06/06/2025 |
| Mr. Paul J. Hastings |
Chief Executive Officer and Director |
美元 648.45K |
21/04/2025 |
| Dr. Nadir Mahmood, PhD |
President, Chief Financial Officer and Principal Accounting Officer |
美元 226.35K |
06/06/2025 |
|
|
| Dr. George Vratsanos, M.D. |
Independent Director |
21/04/2025 |
| Dr. Simeon J. George, M.B.A.,M.D. |
Independent Director |
21/04/2025 |
| Mr. Paul J. Hastings |
Chief Executive Officer and Director |
21/04/2025 |
| Ms. Angela Thedinga |
Independent Director |
21/04/2025 |
| Dr. Zachary Scheiner, PhD |
Independent Director |
21/04/2025 |
| Ms. Leone D Patterson |
Independent Director |
21/04/2025 |
| Dr. Ali Behbahani, M.B.A.,M.D. |
Chairman of the Board |
21/04/2025 |
| Dr. Michael Dybbs, PhD |
Independent Director |
21/04/2025 |
|
|
|
|
